Publications

SARS-CoV-2 seroprevalence, cumulative infections, and immunity to symptomatic infection - A multistage national household survey and modelling study, Dominican Republic, June-October 2021.

Nilles, EJ; Paulino, CT; De St Aubin, M; Restrepo, AC; Mayfield, H; Dumas, D; FINCH, E; Garnier, S; Etienne, MC; Iselin, L; Duke, W; Jarolim, P; Oasan, T; Yu, J; Wan, H; Peña, F; Iihoshi, N; Abdalla, G; Lopez, B; Cruz, LD L; Henríquez, B; Espinosa-Bode, A; Puello, YC; Durski, K; Baldwin, M; ... Lau, CL.

2022

Lancet regional health Americas, (2022).16, 10.1016/j.lana.2022.100390.

Quantifying the primary and secondary effects of antimicrobial resistance on surgery patients: Methods and data sources for empirical estimation in England.

NAYLOR, NR; Evans, S; Pouwels, KB; Troughton, R; Lamagni, T; Muller-Pebody, B; KNIGHT, GM; Atun, R; Robotham, JV;

2022

Frontiers in Public Health, (2022).10, 10.3389/fpubh.2022.803943.

Neurodevelopmental and growth outcomes after invasive Group B Streptococcus in early infancy: A multi-country matched cohort study in South Africa, Mozambique, India, Kenya, and Argentina.

PAUL, P; CHANDNA, J; PROCTER, SR; Dangor, Z; Leahy, S; Santhanam, S; John, HB; Bassat, Q; Bramugy, J; Bardají, A; Abubakar, A; Nasambu, C; Libster, R; Yanotti, CS; Seedat, F; Horváth-Puhó, E; Hossain, AK M T; Sadeq-Ur Rahman, Q; JIT, M; Newton, CR; Milner, K; Gonçalves, BP; LAWN, JE; GBS long term outcomes LMIC collaborative group,;

2022

EClinicalMedicine, (2022).47, 10.1016/j.eclinm.2022.101358.

gwenknight/strain_growth.

KNIGHT, G; Baede, VO;

2022

, Github (2022).

ISIDLSHTM/Model_Size_Selection.

BENEST, J; Rhodes, S; Evans, TG; WHITE, RG;

2022

, Github (2022).

Editorial.

De Angelis, D; Birrell, P; FUNK, S; House, T;

2022

Statistical methods in medical research, (2022).31 9 10.1177/09622802221118613.

Estimating RSV seasonality from pandemic disruptions: a modelling study.

KRAUER, F; Fjelde, TE; KOLTAI, M; HODGSON, D; Treskova-Schwarzbach, M; Harvey, C; JIT, M; Wichmann, O; Harder, T; Flasche, S;

2022

medRxiv (2022). 10.1101/2022.06.18.22276591.

Estimating the cost-effectiveness of maternal vaccination and monoclonal antibodies for respiratory syncytial virus in Kenya and South Africa.

KOLTAI, M; Moyes, J; Nyawanda, B; Nyiro, J; Munywoki, P; Tempia, S; Li, X; Antillon, M; Bilcke, J; Flasche, S; Beutels, P; Nokes, J; Cohen, C; JIT, M;

2022

medRxiv (2022). 10.1101/2022.09.09.22279780.

Unmasking Pneumococcal Carriage in a High Human Immunodeficiency Virus (HIV) Prevalence Population in two Community Cohorts in South Africa, 2016-2018: The PHIRST Study.

Carrim, M; Tempia, S; THINDWA, D; Martinson, NA; Kahn, K; FLASCHE, S; Hellferscee, O; Treurnicht, FK; McMorrow, ML; Moyes, J; Mkhencele, T; Mathunjwa, A; Kleynhans, J; Lebina, L; Mothlaoleng, K; Wafawanaka, F; Gómez-Olivé, FX; Cohen, C; Von Gottberg, A; Wolter, N; PHIRST group,;

2022

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, (2022).76 3 10.1093/cid/ciac499.

RESIST2: Policy.

Knight, G;

2022

, London School of Hygiene & Tropical Medicine (2022). 10.17037/PUBS.04669769.